Preventing Celiac Disease by Weaning With Mediterranean Diet

Trial statusNot yet recruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age1-10
SponsorUniversity of Naples

About this trial

Background: The introduction of solid foods in alignment with the Mediterranean Diet (MD) post-exclusive milk feeding has been demonstrated to cultivate a lasting affinity for healthy eating during infancy and childhood. Despite this, access to healthy diets remains a challenge for numerous children, particularly in underserved areas. The clinical trial under discussion is set in Scampia, a municipality in Naples, Italy, known for its dense population and socio-economic challenges. This trial, utilizing the Family Pediatrician (FP) system, aims to promote MD nutrition among children in Scampia to potentially prevent or reduce chronic childhood diseases.

Study Design: In this pragmatic trial, FPs are utilized as the unit for randomization to administer the intervention. The intervention group will be introduced to an intensified MD-based diet from weaning, incorporating adult-type MD foods, while the control group will follow standard regional dietary guidelines. Dietary adherence and health outcomes are to be periodically monitored, and genetic and microbiome analyses will be conducted using collected saliva and stool samples. Incorporating a Bayesian group sequential design, this trial is structured to conduct interim analyses for efficacy, aligning with local healthcare systems for optimal resource allocation.

Conclusion: The study is poised to be methodologically innovative and socially impactful, utilizing existing healthcare frameworks to enhance childhood nutrition in challenging environments. Outcomes from this trial are expected to provide valuable insights into the effects of MD-based nutrition on child health and potentially serve as a model for promoting healthier diets in urban suburbs globally.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

- Healthy newborns with a birth weight greater than 2000 grams.

Residence in Municipality 8, Piscinola-Scampia.

Disqualifiers

- Newborns suffering from severe prematurity.

Newborns with congenital malformations.

Newborns afflicted by severe diseases.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Weaning by Mediterranean Diet

    Dietary supplement

    Introduce solid foods typical of the Mediterranean Diet at weaning of infants

Treatment groups

3,200 Participants
are divided into 2 treatment groups
Group A: CONTROLSPlacebo comparator 1 intervention
Group B: TreatedExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Incidence of Celiac Disease

Monitoring the incidence of Celiac Disease in the study population.

Time frame
3 to 6 years of age
2

Children growth

Calculating the Body Mass Index (BMI kg/m\^2) as a measure of growth, assessing if children's BMI falls within the normal range for their age and sex.

Time frame
4 to 6 years

Secondary outcomes

1

Beneficial Microbiome

Evaluating the composition of the microbiome for beneficial characteristics.

Time frame
5 to 6 years of age
2

Bifidibacteriaceae in the feces

Measuring the variation of Bifidobacteria in feces.

Time frame
5 years

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: